Treatment of late sequelae after radiotherapy for head and neck cancer

P Strojan, KA Hutcheson, A Eisbruch, JJ Beitler… - Cancer treatment …, 2017 - Elsevier
Radiotherapy (RT) is used to treat approximately 80% of patients with cancer of the head
and neck. Despite enormous advances in RT planning and delivery, a significant number of …

Interventions for the management of radiotherapy-induced xerostomia and hyposalivation: A systematic review and meta-analysis

V Mercadante, A Al Hamad, G Lodi, S Porter, S Fedele - Oral oncology, 2017 - Elsevier
Introduction Salivary gland hypofunction is a common and permanent adverse effect of
radiotherapy to the head and neck. Randomised trials of available treatment modalities have …

Medication-related osteonecrosis of the jaw: MASCC/ISOO/ASCO clinical practice guideline

N Yarom, CL Shapiro, DE Peterson… - Journal of Clinical …, 2019 - ascopubs.org
PURPOSE To provide guidance regarding best practices in the prevention and
management of medication-related osteonecrosis of the jaw (MRONJ) in patients with …

Osteonecrosis of the jaw and antiresorptive agents in benign and malignant diseases: a critical review organized by the ECTS

AD Anastasilakis, J Pepe, N Napoli… - The Journal of …, 2022 - academic.oup.com
Context Antiresorptive therapy significantly reduces fracture risk in patients with benign bone
disease and skeletal-related events (SREs) in patients with bone metastases (BM) …

Managing xerostomia and salivary gland hypofunction: executive summary of a report from the American Dental Association Council on Scientific Affairs

JM Plemons, I Al-Hashimi, CL Marek - The Journal of the American Dental …, 2014 - Elsevier
ABSTRACT Background and Overview Xerostomia, also known as “dry mouth,” is a common
but frequently overlooked condition that is typically associated with salivary gland …

A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life

SB Jensen, AML Pedersen, A Vissink… - Supportive care in …, 2010 - Springer
Purpose This systematic review aimed to assess the literature for prevalence, severity, and
impact on quality of life of salivary gland hypofunction and xerostomia induced by cancer …

Xerostomia induced by radiotherapy: an overview of the physiopathology, clinical evidence, and management of the oral damage

R Pinna, G Campus, E Cumbo, I Mura… - … and clinical risk …, 2015 - Taylor & Francis
Background The irradiation of head and neck cancer (HNC) often causes damage to the
salivary glands. The resulting salivary gland hypofunction and xerostomia seriously reduce …

Salivary gland hypofunction and/or xerostomia induced by nonsurgical cancer therapies: ISOO/MASCC/ASCO guideline

V Mercadante, SB Jensen, DK Smith… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE To provide evidence-based recommendations for prevention and management
of salivary gland hypofunction and xerostomia induced by nonsurgical cancer therapies …

Interventions for the management of dry mouth: topical therapies

S Furness, HV Worthington, G Bryan… - Cochrane Database …, 2011 - cochranelibrary.com
Background Xerostomia (the feeling of dry mouth) is a common symptom especially in older
adults. Causes of dry mouth include medications, autoimmune disease (Sjögren's …

Basic oral care for hematology–oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational …

S Elad, JE Raber-Durlacher, MT Brennan… - Supportive Care in …, 2015 - Springer
Purpose Hematology–oncology patients undergoing chemotherapy and hematopoietic stem
cell transplantation (HSCT) recipients are at risk for oral complications which may cause …